← FDA Drug Approvals (Drugs@FDA)

ALBENDAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-09-04

Drug application

FDA Application #

ANDA215652

Application type

Abbreviated New Drug Application (Generic)

Brand name

ALBENDAZOLE

Generic name

ALBENDAZOLE

Active ingredients

ALBENDAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2024-09-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown